macrophage-deactivating agent used to treat experimental autoimmune encephalomyelitis in mice; prevents postoperative ileus in mice independently of anti-inflammatory vagus nerve signaling
Also Known As:
AXD-455; AXD455; CNI 1493; CNI-1493; CPSI 2364; CPSI-2364; CPSI-2364 free base; CPSI2364; N,N'-bis(3,5-bis(1-((aminoiminomethyl)hydrazono)ethyl)phenyl)decanediamide tetrahydrochloride; N,N'-bis(3,5-bis(1-(carbamimidoylhydrazono)ethyl)phenyl)decanediamide; decanediamide, N1,N10-bis(3,5-bis(1-(2-(aminoiminomethyl)hydrazinylidene)ethyl)phenyl)-, hydrochloride (1:4); decanediamide, N1,N10-bis(3,5-bis(1-(2-(aminoiminomethyl)hydrazinylidene)ethyl)phenyl)-, hydrochloride, hydrate (1:2:4); decanediamide, N1,N10-bis(3,5-bis(1-(2-(aminoiminomethyl)hydrazinylidene)ethyl)phenyl)-, methanesulfonate; semapimod HCl; semapimod hydrochloride; semapimod hydrochloride dihydrate; semapimod mesylate; semapimod tetrahydrochloride; semapimod tetramesylate